We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+12.05%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$362M
AUM Growth
+$64.2M
Cap. Flow
+$28.6M
Cap. Flow %
7.9%
Top 10 Hldgs %
31.1%
Holding
62
New
5
Increased
37
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$4.61M
2
STE icon
Steris
STE
+$4.13M
3
IDXX icon
Idexx Laboratories
IDXX
+$2.03M
4
ROP icon
Roper Technologies
ROP
+$1.78M
5
SPGI icon
S&P Global
SPGI
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 32.57%
2 Industrials 22.38%
3 Healthcare 13.49%
4 Financials 12.79%
5 Consumer Discretionary 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$340B
$7.27M 2.01%
13,804
+191
+1% +$102K
FISV
27
Fiserv Inc
FISV
$26.4B
$7.23M 2%
54,460
+12,578
+30% +$1.54M
ACGL icon
28
Arch Capital
ACGL
$33.2B
$6.81M 1.88%
91,674
+13,660
+18% +$1.12M
TMO icon
29
Thermo Fisher Scientific
TMO
$241B
$6.75M 1.86%
12,713
+319
+3% +$154K
APD icon
30
Air Products & Chemicals
APD
$64.1B
$6.69M 1.85%
24,438
+1,398
+6% +$384K
HD icon
31
Home Depot
HD
$306B
$6.65M 1.84%
19,200
-42
-0.2% -$13K
INTU icon
32
Intuit
INTU
$86.2B
$6.62M 1.83%
10,589
+359
+4% +$198K
VRSN icon
33
VeriSign
VRSN
$27.2B
$6.11M 1.69%
29,682
+564
+2% +$117K
DHR icon
34
Danaher
DHR
$148B
$6.11M 1.69%
26,404
-2,939
-10% -$625K
IEX icon
35
IDEX
IEX
$16.4B
$6.04M 1.67%
27,830
+3,024
+12% +$610K
IR icon
36
Ingersoll Rand
IR
$28.1B
$5.8M 1.6%
75,004
+4,467
+6% +$305K
WCN
37
Waste Connections
WCN
$39.6B
$5.59M 1.54%
37,422
+616
+2% +$84.6K
POOL icon
38
Pool Corp
POOL
$6.21B
$5.55M 1.53%
13,917
-4,349
-24% -$1.52M
ABT icon
39
Abbott
ABT
$178B
$5.38M 1.48%
48,842
+189
+0.4% +$18.9K
MTD icon
40
Mettler-Toledo International
MTD
$28B
$5.1M 1.41%
4,201
-629
-13% -$680K
HEI icon
41
HEICO Corp
HEI
$42.2B
$5.07M 1.4%
28,362
+1,826
+7% +$309K
WST icon
42
West Pharmaceutical
WST
$25.8B
$4.59M 1.27%
+13,033
New +$4.61M
STE icon
43
Steris
STE
$20.7B
$4.29M 1.19%
+19,530
New +$4.13M
CHD icon
44
Church & Dwight Co
CHD
$22.6B
$4.29M 1.18%
45,353
+970
+2% +$88.8K
NKE icon
45
Nike
NKE
$53.8B
$3.97M 1.1%
36,593
-972
-3% -$104K
AMT icon
46
American Tower
AMT
$83.2B
$3.06M 0.85%
14,180
+2,465
+21% +$466K
MKC icon
47
McCormick & Company Non-Voting
MKC
$13.6B
$2.94M 0.81%
42,937
-6,896
-14% -$451K
EXR icon
48
Extra Space Storage
EXR
$29B
$1.09M 0.3%
+6,799
New +$865K
TROW icon
49
T. Rowe Price
TROW
$22.1B
$818K 0.23%
7,600
-250
-3% -$24.9K
CVX icon
50
Chevron
CVX
$417B
$697K 0.19%
4,675
-17
-0.4% -$2.57K

Similar funds

Carderock Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Carderock Capital Management held 62 positions worth $362M, up 22% from $298M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Carderock Capital Management deployed $28.6M of net new capital in Q4 2023, opening 5 new positions and adding to 37 existing holdings. Its largest new stake was West Pharmaceutical: 13,033 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Pool Corp, an estimated $1.52M trimmed.

  • Carderock Capital Management's largest Q4 2023 buy was West Pharmaceutical: 13,033 shares worth $4.59M.
  • Carderock Capital Management added most to Idexx Laboratories in Q4 2023, an estimated $2.03M increase.
  • Carderock Capital Management's biggest Q4 2023 reduction was Pool Corp, cutting an estimated $1.52M.
  • Carderock Capital Management fully exited Enphase Energy in Q4 2023, selling an estimated $1.53M.
  • Carderock Capital Management's ten largest holdings make up 31% of its $362M portfolio in Q4 2023.
  • Carderock Capital Management opened 5 new positions and closed 1 in Q4 2023.
  • Carderock Capital Management's portfolio value rose 22% quarter-over-quarter to $362M.

Based on Carderock Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.